US equities |
MU $989.04 ▲+0.00% SNDK $1,487.33 ▲+0.00% NVDA $226.32 ▲+0.00% SKHY $162.23 ▲+0.00% GS $893.95 ▲+0.00% UNH $378.52 ▲+0.00% INTC $101.35 ▲+0.00% JPM $334.30 ▲+0.00%
FinancialContent

Omada Health, Inc. - Common Stock (NQ:OMDA)

21.87 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Omada Health, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30% 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program
New model demonstrates the clinical and economic value of medication persistence, companion program engagement, and projected disease risk reduction 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition
From Omada Health, Inc.
Via GlobeNewswire
News headline image
UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Host its First Investor Day on September 10, 2026
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Participate in Goldman Sachs Global Healthcare Conference
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support
Survey of more than 3,000 GLP‑1 patients reveals care gaps and rising out‑of‑pocket costs, underscoring employers’ need to pair flexible GLP‑1 access with ongoing lifestyle support 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Reports First Quarter 2026 Results
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds
In a 12‑week comparative study, Omada GLP‑1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls, pointing to increased value for employers... 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care
Through Omada’s GLP-1 Flex Care offering, employers gain a new flexible option to connect employees with anti-obesity medication, virtual care, and lifestyle support 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Reports Fourth Quarter and Full-Year 2025 Results
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
Omada for Cholesterol closes a critical gap in cardiovascular care, delivering between-visit support for the many adults whose LDL remains uncontrolled under usual care¹ 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Participate in J.P. Morgan Healthcare Conference
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss
New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidence 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Participate in Evercore Healthcare Conference
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population
New capability to provide tailored and coordinated care informed by behavioral insights 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Reports Third Quarter 2025 Results
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users
Results suggest sustained, long-term impact of Omada’s program on weight loss and longer medication persistence 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer
Healthcare veteran brings expertise in clinical care delivery, digital health, and policy to virtual-first healthcare provider 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting
From Omada Health, Inc.
Via GlobeNewswire
News headline image
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions
Analysis shows Omada members maintained weight, with minimal (0.8%) average weight change, one year after discontinuing GLP-1s for weight loss,1 suggesting the impact of continued lifestyle support... 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy
Compared to in-person physical therapy, claims data revealed lower healthcare utilization and spending for patients who used Omada’s programs for musculoskeletal conditions 
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health to Participate in Upcoming Investor Conference
From Omada Health, Inc.
Via GlobeNewswire
News headline image
Omada Health Reports Second Quarter 2025 Results
From Omada Health, Inc.
Via GlobeNewswire
< Previous 1 2 Next >